Basic and Clinical research within the Division of Gastroenterology and Hepatology is active and diverse. We conduct Phase I-IV clinical research trials and have more than xx trials actively underway. Research projects range from bench and animal studies, drug and device trials, to observational and epidemiologic research in a variety of areas, including pancreaticobiliary and esophageal disorders, gastrointestinal cancer, nutrition, inflammatory bowel disease (IBD) and liver disease.
In addition to conducting research within their home division, GI faculty are active in research organizations in the larger MUSC community. They form the administrative and scientific foundation of the MUSC Digestive Disease Research Center, an organization that supports collaborative biomedical research in digestive and liver diseases across the University.
Through research collaborations, GI faculty interact with investigators in a number of other research units at MUSC including the Hollings Cancer Center, an NCI-designated cancer center.
MUSC GI faculty are recognized nationally and internationally for their scholarly contributions to gastroenterology. They are represented among the leadership of several national GI societies including the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy and the American Association for the Study of Liver Diseases.